School of Medicine
Showing 1-20 of 76 Results
Laura Michele Hack
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Laura Hack is an Instructor in the Department of Psychiatry and Behavioral Sciences, Director of Novel & Precision Neurotherapeutics at the Stanford Center for Precision Mental Health and Wellness, and Deputy Director of the Precision Neuromodulation Clinic (PNC) within the VA Palo Alto Health Care System. Dr. Hack's translational research program focuses on identifying bioclinical subtypes of depression and testing mechanistically-guided treatments for these subtypes. Clinically, she specializes in delivering novel treatments, including neuromodulation and ketamine, to patients suffering from treatment resistant depression and related disorders.
Sarah Louise Hagerty
Postdoctoral Scholar, Psychiatry
BioSarah Hagerty, Ph.D., is a postdoctoral fellow at Stanford University and the Sierra Pacific Mental Illness Research Education and Clinical Center (MIRECC) at the VA Palo Alto Health Care System. She graduated with a BA in Psychology from Carleton College. Recently, she completed dual PhDs in Clinical Psychology and Neuroscience at University of Colorado Boulder and pre-doctoral clinical internship at the VA Palo Alto Health Care System. Broadly, Sarah is interested in identifying clinically meaningful patient subtypes based on multimodal data, which could inform personalized interventions. Ultimately, Sarah imagines a new way of conceptualizing psychiatric diagnoses, such that an understanding of biology and behavior yield precision diagnostic insights on a more nuanced, individualized basis. Sarah sees her clinical work as a rich source for scientific hypotheses and personal inspiration, and clinical interactions serve as an important reminder of her dedication to reduce human suffering and increase fulfillment through her program of research A native of Colorado, Sarah is happiest when she's on a hiking trail, playing soccer, or spending time with family.
Scott S. Hall, Ph.D
Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences)
Current Research and Scholarly InterestsMy primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.
Haijing Wu Hallenbeck
Postdoctoral Scholar, Psychiatry
BioHaijing Hallenbeck, Ph.D., is a postdoctoral fellow at the National Center for PTSD at VA Palo Alto Health Care System, in conjunction with Stanford University School of Medicine. After completing her internship at VA Palo Alto Health Care System, she earned her Ph.D. in clinical psychology from Washington University in St. Louis. Haijing's graduate work focused on using mobile app technology for the assessment of depression. As a postdoctoral fellow, she is investigating how this technology can be adapted for purposes of treatment, particularly for PTSD and depression. She is interested in optimizing mobile apps to improve both mental health symptoms and psychosocial functioning for individuals.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsPrincipal Investigator
Infrastructure to facilitate discovery of autism genes
The purpose of this project is to facilitate the discovery of the genes that contribute autism by maintaining an infrastructure which research groups studying the genetics of autism can work collaboratively. This will be
accomplished through workshops, a Virtual Private Network, and access to a database that includes phenotype and genotype data from all participating groups.
A California Population-Based Twin Study of Autism
This will address several fundamental questions: (1) What is the heritability of autism (2) What is the contribution of genetic factors to variation in symptom dimensions? (3) Is there a continuum between the quantitative neurocognitive traits and clinical disorder? (4) What proportion of the variance in the neurocognitive traits is accounted for by genetic and non-genetic factors?
Center for Integrating Ethics in Genetics Research(Cho)
The goal of this project is to serve as a center of excellence in neurogenetics research, to develop a national model for bench, to bedside research ethics consultation, and to provide training opportunity in biomedical ethics.
Gene, Brain and Behavior in Turner Syndrome(Reiss)
The primary objective of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, analyses of X chromosome parent-of-origin and cognitive-behavioral assessment to elucidate the effects of monosomy and X-linked imprinting on neurodevelopment and neural function in a large cohort of young girls with Turner syndrome, pre-estrogen replacement.
Project F: Genomic Analysis in narcolepsy cataplexy
The goal of the project is to locate genes outside the HLA region that influence susceptibility to narcolepsy. In order to localize these genes we will carry out a linkage and association study in the most extensive world-wide collection of DNAs from well-characterized patients with narcolepsy and their families.
Professor of Pediatrics (Adolescent Medicine) and, by courtesy, of Epidemiology and Population Health and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsResearch focuses on developmental, cognitive and psychosocial factors involved in adolescents’ and young adults’ health-related decision-making, perceptions of risk and vulnerability, health communication and risk behavior. My research has focused on understanding and reducing health risk behaviors such as tobacco use, alcohol and marijuana use, risky driving, and risky sexual behavior.
Public Rel Offcr 2, Psychiatry and Behavioral Sciences
Current Role at StanfordWeb & Communications Administration
Psychiatry and Behavioral Sciences (http://med.stanford.edu/psychiatry.html)
Antonio Hardan, M.D.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe neurobiology of autism
Neuroimaging in individuals with autism
Psychopharmacological treatment of children and adults with autism and/or developmental disorders
The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations).
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.
Earth Hasassri, MD
Affiliate, Dean's Office Operations - Dean Other
Fellow in Psychiatry and Behavioral Sciences
BioDr. Earth Hasassri is a Clinical Fellow of Child & Adolescent Psychiatry within the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and Lucile Packard Children's Hospital at Stanford. He specializes in seeing patients for complex psychiatric conditions such as psychotic experiences and autism spectrum disorders. His interests are caring for individuals who suffer from medical conditions at the interface of medicine and psychiatry. In addition, he treats children with a broad range of psychiatric disorders including neurodevelopmental disorders, ADHD and mood and anxiety disorders in adolescents.
Prior to medical school, Dr. Hasassri graduated with dual bachelor's degrees in neurophysiology and psychology at the University of California San Diego, where he performed research on sleep medicine. He earned his medical degree from the Mayo Clinic Alix School of Medicine where he did research in clinical epidemiology. Dr. Hasassri completed his residency in general psychiatry at the University of California San Francisco Langley Porter Psychiatric Hospitals & Clinics, during which he was awarded an Area of Distinction in Clinical Neuroscience for his work in applying neuroscientific principles in his clinical work in those with brain cancer, dementia, neurodevelopmental disorders, and other neuropsychiatric conditions. Dr. Hasassri is a board certified general psychiatrist and is currently pursuing further training through a fellowship here at Stanford to obtain subspecialty board certification in child and adolescent psychiatry.
Dr. Hasassri's scientific interest focus on bringing novel interventional treatments to children and adolescents, such as transcranial magnetic stimulation. He is currently working with Dr. Nolan Williams and Dr. Antonio Hardan in their laboratories studying whether transcranial magnetic stimulation is safe and effective for children and adolescents, particularly in those with autism spectrum disorders.